Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 47

Sort by

Sort Order Select

Journal Articles

TCR γδ Large Granular Lymphocyte Leukemia (LGLL) Displays Features between CD8+ and CD4+ TCR αβ LGLL

Antonella Teramo, Elena Ciabatti, Giulia Tarrini, Iacopo Petrini, Gregorio Barilà, MD, Giulia Calabretto, Cristina Vicenzetto, Matteo Leoncin, MD, Anna Cabrelle, Francesco Piazza, MD, Sara Galimberti, PhD MD, Roberto Grossi, Nadia Pisanti, Gianpietro Semenzato, MD, Renato Zambello, MD

Blood (2017) 130 (Supplement 1): 5327.

https://doi.org/10.1182/blood.V130.Suppl_1.5327.5327

Published: 2017

Journal Articles

Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea

Chi A. Ma, Liqiang Xi, Brian Cauff, Adam DeZure, Alexandra F. Freeman, Sophie Hambleton, Gary Kleiner, T. Ronan Leahy, Maureen O’Sullivan, Michelle Makiya, Grainne O’Regan, Stefania Pittaluga, Julie Niemela, Jennifer Stoddard, Sergio D. Rosenzweig, Mark Raffeld, Amy D. Klion, Joshua D. Milner

Blood (2017) 129 (5): 650–653.

https://doi.org/10.1182/blood-2016-09-737817

Published: 2017

Includes: Supplemental data

Journal Articles

Subset-Specific Recurrence of Mutations and Identification of Functional Modules Provides New Clues about the Pathogenesis of Large Granular Lymphocyte Leukemia

Alessandro Coppe, BSc, PhD, Emma I Andersson, MSc, Andrea Binatti, BSc, Vanessa R Gasparini, Sabrina Bortoluzzi, Michael J. Clemente, M.S., Marco Herling, MD PhD, Jaroslaw P. Maciejewski, MD, PhD, FACP, Satu Mustjoki, MD PhD, Stefania Bortoluzzi, BSc, PhD

Blood (2016) 128 (22): 4117.

https://doi.org/10.1182/blood.V128.22.4117.4117

Published: 2016

Journal Articles

High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia

Blood (2016) 128 (20): 2465–2468.

https://doi.org/10.1182/blood-2016-06-724856

Published: 2016

Includes: Supplemental data

Journal Articles

Microrna-150 Regulates STAT5b Levels in Juvenile Myelomonocytic Leukemia (JMML)

Pier Paolo Leoncini, PhD, Alice Bertaina, MDPhD, Dimitrios Papaioannou, MD, Christian Flotho, Riccardo Masetti, MD, Silvia Bresolin, PhD, Giuseppe Menna, MD, Nicola Santoro, Marco Zecca, MD, Giuseppe Basso, Prof, MD, Giovanni Nigita, PhD, Sara Pagotto, PhD, Katia D'Ovidio, PhD, Rossella Rota, Carlo M. Croce, MD, Charlotte Marie Niemeyer, Prof, MD, Franco Locatelli, MD PhD, Ramiro Garzon, MD

Blood (2015) 126 (23): 2851.

https://doi.org/10.1182/blood.V126.23.2851.2851

Published: 2015

Journal Articles

Exome Sequencing of Aggressive Natural Killer Cell Leukemia and Drug Profiling Highlight Candidate Driver Pathways in Malignant Natural Killer Cells

Blood (2015) 126 (23): 700.

https://doi.org/10.1182/blood.V126.23.700.700

Published: 2015

Journal Articles

Drug Sensitivity Profiling Identifies Drugs for Targeting Constitutively Active Mutant STAT3 and Mutant STAT5B Positive Malignancies

Heikki Kuusanmäki, MSc, Hanna Rajala, MD PhD, Arjan van Adrichem, Muntasir Mamun Majumder, MSc,BPharm, Emma I Andersson, MSc, Krister Wennerberg, PhD, Satu Mustjoki, MDPhD, Caroline A Heckman, PhD

Blood (2014) 124 (21): 1771.

https://doi.org/10.1182/blood.V124.21.1771.1771

Published: 2014

Journal Articles

STAT5b Gene Mutations and Their Association with a Unique Immunophenotype of CD4+CD56+TCRαβ Type LGL Leukemia

Takahiro Tanahashi, Kazuyuki Matsuda, PhD, Nodoka Sekiguchi, MD PhD, Sayaka Nishina, MD, Noriko Senoo, MD, Kaoko Sakai, Hitoshi Sakai, MD, Toshiro Ito, MD PhD, Takeki Mitsui, MD, PhD, Yok Lam Kwong, MD, Fumihiro Ishida, MD PhD

Blood (2014) 124 (21): 1652.

https://doi.org/10.1182/blood.V124.21.1652.1652

Published: 2014

Journal Articles

Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia

Mark J. Kiel, Thirunavukkarasu Velusamy, Delphine Rolland, Anagh A. Sahasrabuddhe, Fuzon Chung, Nathanael G. Bailey, Alexandra Schrader, Bo Li, Jun Z. Li, Ayse B. Ozel, Bryan L. Betz, Roberto N. Miranda, L. Jeffrey Medeiros, Lili Zhao, Marco Herling, Megan S. Lim, Kojo S. J. Elenitoba-Johnson

Blood (2014) 124 (9): 1460–1472.

https://doi.org/10.1182/blood-2014-03-559542

Published: 2014

Includes: Supplemental data

Journal Articles

Novel Activating STAT5B Mutations As Drivers Of T-ALL

Mika Kontro, MD, Heikki Kuusanmäki, MSc, Samuli Eldfors, MSc, Tea Pemovska, MSc, Hanna L M Rajala, MD, Henrik Edgren, PhD, Pekka Ellonen, MSc, Sonja Lagström, MSc, Tuija Lundán, PhD, Olli Kallioniemi, MD, PhD, Satu Mustjoki, MD, PhD, Kimmo Porkka, MD, PhD, Caroline Heckman, PhD

Blood (2013) 122 (21): 3863.

https://doi.org/10.1182/blood.V122.21.3863.3863

Published: 2013

Journal Articles

Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia

Blood (2013) 121 (22): 4541–4550.

https://doi.org/10.1182/blood-2012-12-474577

Published: 2013

Includes: Supplemental data

Journal Articles

Biologic Activity of STAT5A and STAT5B in Waldenstrom's Macroglobulinemia.

Lucy S. Hodge, PharmD, Ph.D., Steven C. Ziesmer, Frank J Secreto, Ph.D., Zhi-Zhang Yang, MD, Anne J. Novak, Ph.D., Stephen M. Ansell, M.D., Ph.D.

Blood (2012) 120 (21): 2688.

https://doi.org/10.1182/blood.V120.21.2688.2688

Published: 2012

Journal Articles

The Potential Role of STAT's in Anti-Leukemic Therapy with Different Drugs

Hatice Demet Kiper, Burcin Tezcanli Kaymaz, Ozlem Purclutepe, Ceyda Tunakan Dalgic, Nur Selvi, Aysegul Dalmizrak, Cigir Biray Avci, Buket Kosova, Fahri Sahin, Cagdas Aktan, Guray Saydam, MD

Blood (2012) 120 (21): 5120.

https://doi.org/10.1182/blood.V120.21.5120.5120

Published: 2012

Journal Articles

Discovery of STAT5b Mutations and Small Subclones of STAT3 Mutations in Large Granular Lymphocytic (LGL) Leukemia

Blood (2012) 120 (21): 871.

https://doi.org/10.1182/blood.V120.21.871.871

Published: 2012

Journal Articles

Src Kinases Act Downstream Akt and Are Required for the Transforming Properties of Constitutively Activated Forms of STAT5A and STAT5B

Remy Nyga, Lea Savay, Ingrid Marcq, Aline Regnier, Gandhi Damaj, MD, Jacques Rochette, Fabrice Gouilleux, PhD, Kaiss Lassoued, MD. PhD.

Blood (2011) 118 (21): 2378.

https://doi.org/10.1182/blood.V118.21.2378.2378

Published: 2011

Journal Articles

Generation of a Transgenic Mouse with Inducible Constitutively Active Stat5a,

Harini Nivarthi, Andriy Tsyrulnyk, Wolfgang Warsch, Zhengqi Wang, Susanne Winkler, Lukas Kenner, MD, Mathias Müller, DVM, Christopher Baum, MD, Kevin D. Bunting, PhD, Veronika Sexl, MD, Thomas Rülicke, D.V.M., Richard Moriggl, PhD

Blood (2011) 118 (21): 3399.

https://doi.org/10.1182/blood.V118.21.3399.3399

Published: 2011

Journal Articles

MHC Class II and T Cell Receptor Signals Are Dispensable for IL-2-Induced Regulatory T Cell Proliferation In Vivo

Tao Zou, B.S., Atsushi Satake, M.D., Jonathan Maltzman, MD, PhD, Taku Kambayashi, MD, PhD

Blood (2011) 118 (21): 2181.

https://doi.org/10.1182/blood.V118.21.2181.2181

Published: 2011

Journal Articles

IL7Rα Signaling Prevents Premature Expression of AID In Human Pre-B Cells: Implications for Clonal Evolution of Childhood Leukemia

Srividya Swaminathan, Lars Klemm, Soo-mi Kweon, Anthony Ford, Klaus Schwarz, Rafael Casellas, Lothar Hennighausen, David G. Schatz, Michael R. Lieber, Mel F. Greaves, Markus Muschen

Blood (2010) 116 (21): 26.

https://doi.org/10.1182/blood.V116.21.26.26

Published: 2010

Journal Articles

Distinct Functions of Stat5A and Stat5B in Chronic Myeloid Leukemia (CML): Stat5B Is Implicated in Survival and Self-Renewal and Stat5A in Imatinib Resistance.

Imen Najjar, PhD, Adrien Grimont, Nicolas Martin, Severine Martin-Lanneree, Marie Laure Bonnet, Francois Guilhot, Jean-Claude Chomel, Evelyne Lauret, Ali G. Turhan, MD, PhD, Isabelle Dusanter-Fourt, PhD

Blood (2010) 116 (21): 1214.

https://doi.org/10.1182/blood.V116.21.1214.1214

Published: 2010

Journal Articles

Constitutively active Stat5b in CD4 + T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses

Christine Vogtenhuber, Christoph Bucher, Steven L. Highfill, Lisa K. Koch, Emily Goren, Angela Panoskaltsis-Mortari, Patricia A. Taylor, Michael A. Farrar, Bruce R. Blazar

Blood (2010) 116 (3): 466–474.

https://doi.org/10.1182/blood-2009-11-252825

Published: 2010

Includes: Supplemental data

NARROW

TCR γδ Large Granular Lymphocyte Leukemia (LGLL) Displays Features between CD8+ and CD4+ TCR αβ LGLL

Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea

Subset-Specific Recurrence of Mutations and Identification of Functional Modules Provides New Clues about the Pathogenesis of Large Granular Lymphocyte Leukemia

High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia

Microrna-150 Regulates STAT5b Levels in Juvenile Myelomonocytic Leukemia (JMML)

Exome Sequencing of Aggressive Natural Killer Cell Leukemia and Drug Profiling Highlight Candidate Driver Pathways in Malignant Natural Killer Cells

Drug Sensitivity Profiling Identifies Drugs for Targeting Constitutively Active Mutant STAT3 and Mutant STAT5B Positive Malignancies

STAT5b Gene Mutations and Their Association with a Unique Immunophenotype of CD4+CD56+TCRαβ Type LGL Leukemia

Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia

Novel Activating STAT5B Mutations As Drivers Of T-ALL

Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia

Biologic Activity of STAT5A and STAT5B in Waldenstrom's Macroglobulinemia.

The Potential Role of STAT's in Anti-Leukemic Therapy with Different Drugs

Discovery of STAT5b Mutations and Small Subclones of STAT3 Mutations in Large Granular Lymphocytic (LGL) Leukemia

Src Kinases Act Downstream Akt and Are Required for the Transforming Properties of Constitutively Activated Forms of STAT5A and STAT5B

Generation of a Transgenic Mouse with Inducible Constitutively Active Stat5a,

MHC Class II and T Cell Receptor Signals Are Dispensable for IL-2-Induced Regulatory T Cell Proliferation In Vivo

IL7Rα Signaling Prevents Premature Expression of AID In Human Pre-B Cells: Implications for Clonal Evolution of Childhood Leukemia

Distinct Functions of Stat5A and Stat5B in Chronic Myeloid Leukemia (CML): Stat5B Is Implicated in Survival and Self-Renewal and Stat5A in Imatinib Resistance.

Constitutively active Stat5b in CD4 + T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only